Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Oct 29.
Published in final edited form as: Chem Biol. 2010 Oct 29;17(10):1077–1083. doi: 10.1016/j.chembiol.2010.08.007

N-Acylation During Glidobactin Biosynthesis by the Tridomain Nonribosomal Peptide Synthetase Module GlbF

Heidi J Imker 1, Daniel Krahn 2, Jérôme Clerc 2, Markus Kaiser 2, Christopher T Walsh 1,*
PMCID: PMC3062200  NIHMSID: NIHMS275215  PMID: 21035730

Summary

Glidobactins are hybrid NRPS-PKS natural products that function as irreversible proteasome inhibitors. A variety of medium chain 2(E),4(E)-diene fatty acids N-acylate the peptidolactam core and contribute significantly to the potency of proteasome inhibition. We have expressed the initiation NRPS module GlbF (C-A-T) in Escherichia coli and observe soluble active protein only on co-expression with the 8 kDa MbtH-like protein, GlbE. Following adenylation and installation of Thr as a T-domain thioester, the starter condensation domain utilizes fatty acyl-CoA donors to acylate the Thr1 amino group and generate the fatty acyl-Thr1-S-pantetheinyl-GlbF intermediate to be used in subsequent chain elongation. Previously proposed to be mediated via acyl carrier protein fatty acid donors, direct utilization of fatty acyl-CoA donors for N-acylation of T-domain tethered amino acids is likely a common strategy for chain initiation in NRPS-mediated lipopeptide biosynthesis.

Introduction

Syrbactins comprise a family of bacterial N-acylated cyclic depsipeptides with a 12 membered macrolactam ring that covalently targets the active site of proteasomes (Groll et al., 2008). The electrophilic functionality is an α,β-unsatured amide moiety within the macrolactam scaffold that undergoes Michael addition by the N-terminal Thr1–OH active site nucleophile within the proteasome (Figure 1). Two subfamilies within the syrbactins are the syringolins produced by the plant pathogen Pseudomonas syringae B301D-R (Waspi et al., 1998) and the glidobactins from Burkholderia K481-B101 (Oka et al., 1988a) which differ most dramatically in the substituents N-acylating the peptidolactam core.

Figure 1.

Figure 1

Chemical Structures of Glidobactin A and Syringolin A. See also Figure S1

The 12-membered macrolactam is assembled by a non-ribosomal peptide synthase (NRPS) from a tripeptide X1-Lys2-X3 framework where X3 is Ala in glidobactins and Val in syringolins. In each case X3 is further elongated on a hybrid nonribosomal peptide synthetase (NRPS)-polyketide synthase (PKS) assembly line via a Δ2-enoyl group (thereby introducing the electrophile that captures the proteasome) arising from partial processing of a malonyl unit by the PKS module (Amrein et al., 2004) (Schellenberg et al., 2007) (Figure S1). X1 is an N-acylated Val1 in syringolins and an N-acylated Thr1 in glidobactins. The N-acyl moieties are important determinants for potent inhibition of the proteasome, and they differ in syringolins and glidobactins. In syringolins there is an additional Val0 attached to Val1 as an N-ureido-Val0 while in glidobactin Thr1 is N-acylated by medium chain fatty acid monomers. We recently described how the unusual ureido linkage is fashioned by a NRPS module in syringolin assembly (Imker et al., 2009) and now have turned to understanding the parallel step in glidobactin assembly.

Our attention in this work is on the N-acylation of Thr1 in glidobactin scaffolds by dienoic acids, predominantly 2(E),4(E)-dodecadienoic acid. Bioinformatic analysis indicated that the tridomain NRPS GlbF harbors an N-terminal “starter” condensation (C) domain suggesting a direct function for this protein in initiation of glidobactin biosynthesis (Figure 2). Although starter C domains have been repeatedly proposed to catalyze N-acylation in peptide natural products (Baltz et al., 2005) (Rausch et al., 2007), in vitro characterization has been lacking. We demonstrate that the starter C domain of the GlbF protein catalyzes chain-initiating N-acylation of the Thr1-S-pantetheinyl-GlbF intermediate with fatty acyl-CoAs as co-substrates without involvement of an in trans ACP.

Figure 2.

Figure 2

Characterization of the Glidobactin Initiation Module, GlbF.

A) Partial glidobactin cluster.

B) GlbF module organization and putative thioester product.

C) Phylogenetic analysis of C domains including the GlbF starter C domain.

See also Figures S1, S2

Results

GlbF as a Stand Alone Tridomain C-A-T Module Predicted to Carry Out Glidobactin Chain Initiation: Heterologous Protein Production

To evaluate the 118 kDa GlbF as the putative glidobactin biosynthesis chain initiation module, the 3252 bp Burkholderia K481-B101 GlbF gene was subcloned into various vectors for expression in E. coli as His6-tagged constructs. No protein expression was detected despite variations in tag location, IPTG induced expression, or growth temperature. We noted the presence of the predicted 8 kDa orf GlbE, encoded just upstream of GlbF (Figure 2). GlbE is a member of the MbtH family, with the founding member MbtH encoded in the mycobactin siderophore biosynthetic pathway. We recently reported that during characterization of vicibactin biosynthesis, it was optimal to co-express the MbtH homologue VbsG with the NRPS VbsS, and the VbsGS complex co-eluted during purification (Heemstra et al., 2009). To that end tandem co-expression of GlbE and GlbF led to production of soluble GlbF (Figure S2). Notably, nickel affinity purification of C-His6 tagged GlbF (120 kDa) resulted in co-purification of the untagged GlbE (8 kDa). Likewise, nickel affinity purification of N-His6 tagged GlbE resulted in co-purification of the untagged GlbF. Washing of the resin-bound C-His6 GlbF for 16 hours with no salt, 2 M NaCl, 1% Triton X-100, 1 mM DTT, or 1 mM ATP/1mM Thr containing buffer was not sufficient to disrupt the GlbEF interaction (data not shown). Consequently, the complex was further purified by gel filtration and the proteins separated on 4-15% gradient SDS-PAGE gel. The two bands were excised and amino acid content was analyzed by ion exchange following in-gel acid hydrolysis. This analysis showed that the complex consisted of a 1.71:1 GlbE:GlbF stoichiometry when GlbE was His6-tagged and 1.65:1 stoichoimetry when GlbF was His6-tagged. With pure, soluble GlbEF complex obtainable at yields of ~10 mg/liter we could proceed to evaluation of GlbF NRPS activity.

The Adenylation Domain of GlbF Activates and Loads L-Thr as a Thioester on the Holo Form of the T Domain

Based on the domain organization of the two NRPS megasynthetases in the glidobactin gene cluster, GlbF was the most likely candidate for activation and incorporation of the first amino acid, thereby initiating glidobactin biosynthesis. Additionally, the 10 amino acid Stachelhaus motif (DFWNIGMVHK) predicts Thr is the substrate for the GlbF A domain (Stachelhaus et al., 1999) (Rausch et al., 2005). Reversible generation of amino acid adenylates allows for quantification of activation by the classical ATP-32PPi exchange assay. When this assay was carried out with a panel of representative amino acids, GlbF showed strong selectivity towards Thr and Ser substrates (Figure S3). Full kinetic analysis further refined the specificity; while activation of Thr showed prototypical adenylation parameters (kcat = 0.8 s−1, KM = 0.7 mM, kcat/KM = 1.3 × 103 M−1 s−1), saturation kinetics were not achievable for Ser at concentrations less than 10 mM (kcat/KM ~ 1 × 101 M−1 s−1) (Figure S3).

With confirmation that the GlbF A domain activates Thr to generate Thr-AMP in the first reversible half reaction, we then validated the expected second half reaction, transfer of the Thr moiety to the HS-pantetheinyl arm of the T domain of GlbF. For this to occur the apo form of GlbF must be posttranslationally modified such that Ser1018 becomes phosphopantetheinylated in the holo form. This was accomplished with purified GlbF by use of the broad specificity PPTase Sfp using coenzyme A as the co-substrate (Quadri et al., 1998). Covalent loading of 14C-Thr onto the holo T domain of GlbF occurs to 70% calculated stoichiometry (Figure S4). 14C-Ser is also loaded to approximately the same level as Thr, albeit more slowly which is likely a reflection of sub-optimal adenylation.

The Condensation Domain of GlbF Catalyzes Auto N-Acylation of the Thr1-S-T Domain Using Fatty Acyl-CoA Donors

The putative N-acylation activity of the GlbF starter C domain requires access to activated fatty acid donors. Although ACPs had been proposed to be the activating unit used in the biosynthesis of other N-acylated peptidyl natural products (Schellenberg et al., 2007), no ACP was found in the glidobactin gene cluster. Furthermore, early feeding studies indicated that the unusual 2(E),4(E) diene fatty acids were intermediates shunted from β-oxidation of long chain fatty acids (Numata et al., 1988). This observation suggested that the usual diene fatty acids were biosynthesized as CoA thioesters without involvement of dedicated ACPs. Therefore, we synthesized the CoA thioesters of the C10 and C12 2(E),4(E) diene fatty acids as these acids were accessible by commercial or synthetic methods and represented both glidobactin A as the most prominent variant (C12 diene) and glidobactin F as a minimally produced variant (C10 diene). The CoA ester of 2(E),4(E) decadienoic acid was synthesized using standard PyBOP coupling using commercial 2(E),4(E) decadienoic acid (Kopp et al., 2008). In contrast, the CoA ester of synthetically prepared 2(E),4(E) dodecadienoic acid was prepared after activation with ethyl choroformate.

Condensation between fatty acyl-CoA donors and Thr1-S-pantetheinyl-GlbF was tested by in situ generation of the holo GlbF protein followed by addition of the fatty acyl-CoA and ATP. After the 2 hours, the protein was precipitated in methanol and the protein pellet subjected to base hydrolysis to cleave the thioester bound product. After work-up to remove protein and concentrate the sample, the liberated product was analyzed by HR LC-MS for formation of the condensation product. Both 2(E),4(E) dodecadienoyl-Thr and 2(E),4(E) decadienoyl-Thr were readily detected with (M+H)+ ions of 270.1703 (expected m/z 270.1706) and 298.2013 (expected m/z 298.2019), respectively (Figure 3). To confirm that the GlbF starter condensation domain was responsible for acylation of the T domain bound Thr, the conserved catalytic His common to all condensation domains in the HHxxxDG motif (Stachelhaus et al., 1998) was replaced with Ala by site-directed mutagenesis. When assayed as above for condensation activity, no product was detected from reaction with the H141A mutant protein despite being active in adenylation and loading assays.

Figure 3.

Figure 3

HR LC-MS spectra of condensation products hydrolyzed from the GlbF T–domain.

A) 2(E),4(E) dodecadienoyl-Thr Product.

B) 2(E),4(E) decadienoyl-Thr Product.

See also Figures S3, S4, and S5.

In the glidobactin family 6 of the 7 structurally characterized natural products vary only in the constitution of the N-acyl fatty acid. This variability suggests a propensity towards C domain promiscuity and prompted us to test condensation with structurally diverse acyl-CoA donors (Table 1 and Figures S5-6). While donors that deviated from the fatty acid family were not utilized (e.g. benzoyl and isovaleryl CoAs), surprisingly, long chain fatty acid donors were accepted, including palmitoyl- and oleoyl-CoA. However, while the fully saturated dodecanoyl-CoA was not a donor, the singly desaturated 2(E) dodecenoyl-CoA sufficed. Short chain fatty acyl-CoAs, either saturated or desaturated, were not utilized. These results are consistent with semi-synthetic SAR studies conducted shortly after the discovery of glidobactins (Oka et al, 1988b). Despite the ability of GlbF to activate and load Ser (vide supra), 2(E),4(E) dodecadienoyl-Ser and 2(E),4(E) decadienoyl-Ser were not observed. However, none of the glidobactin variants isolated contain Ser at X1 suggesting specificity at this position is strict.

Table 1.

Acyl-CoA Donors Tested for Condensation to Thr1-S-Pantetheinyl-GlbF. See also Figures S5 and S6

CoA Donor Hydrolyzed
Condensation Product
Expected
m/z (M+H)+
Found
m/z (M+H)+
Δ pp
m1
2(E),4(E) decadienoyl-CoA graphic file with name nihms-275215-t0004.jpg 270.1706 270.1703 1.27
2(E),4(E) dodecadienoyl-CoA graphic file with name nihms-275215-t0005.jpg 298.2019 298.2013 0.81
2(E) dodecenoyl-CoA graphic file with name nihms-275215-t0006.jpg 300.2176 300.2168 −0.44
dodecanoyl-CoA graphic file with name nihms-275215-t0007.jpg 302.2332 NONE --
palmitoyl-CoA graphic file with name nihms-275215-t0008.jpg 358.2958 358.2962 −1.18
12-hydroxy-stearioyl-CoA graphic file with name nihms-275215-t0009.jpg 402.3220 NONE --
oleoyl CoA graphic file with name nihms-275215-t0010.jpg 384.3115 384.3109 0.26
hexanoyl-CoA graphic file with name nihms-275215-t0011.jpg 218.1393 NONE --
isovaleryl-CoA graphic file with name nihms-275215-t0012.jpg 204.1237 NONE --
sinapioyl-CoA graphic file with name nihms-275215-t0013.jpg 326.1241 NONE --
benzoyl-CoA graphic file with name nihms-275215-t0014.jpg 224.0924 NONE --
1

Delta parts per million calculated as [(observed m/z − expected m/z)/expected m/z] × 106.

Discussion

While N-acylation has been shown to be a critical feature for efficacy in several cases, including the clinically relevant antibiotic daptomycin (Huber et al., 1988; Baltz et al., 2005), little understanding has been acquired as to the timing and mechanism of acylation. Several groups have noted the conspicuous presence of an N-terminal condensation domain in the initiating module of NRPS assembly lines of N-acylated natural product biosynthetic gene clusters (Baltz et al., 2005; Farnet et al., 2007; Rausch et al., 2007). The presence of these domains in the initiation module indicates that amide bond formation occurs between the activated fatty acyl donor and the aminoacyl1-S-pantetheinyl intermediate before chain elongation and involvement of the next downstream module. Accordingly, these domains were termed “starter” C domains by Rausch et al. during their careful phylogenetic analysis of condensation domain sub-types and include the N-terminal condensation domains of daptomycin, enterobactin, and surfactin (Rausch et al., 2007). We carried out a similar phylogenetic analysis including the GlbF sequence and found that this condensation domain also clearly grouped with other starter C domains (Figure 2).

Along with the proposed role of starter condensation domains as the catalyst for N-acylation, the nature of the activated fatty acid species has been the subject of consideration as well. The presence of acyl-CoA ligases and ACPs in several lipopeptide natural product gene clusters, including CDA, daptomycin, and A54145, led Baltz et al. to propose ACP-mediation as a general strategy in lipopeptide biosynthesis (Baltz et al., 2005). Indeed, the 2,3-epoxyhexanoyl moiety N-acylating the CDA peptide core was shown to be synthesized on a dedicated ACP encoded within the CDA gene cluster (Kopp et al., 2008). Although no in vitro biochemical analysis has been published directly showing condensation between the X1 amino acid and ACP-activated fatty acids, this is likely the mechanism in those systems. Notably, N-acylation of Ser-S-pantetheinyl-EntF with 2,3-dihydroxybenzoate in enterobactin biosynthesis occurs via the ArCP (aryl-carrier protein) containing EntB (Gehring et al., 1998), giving further credence to starter C domain interaction with various carrier proteins. Steller et al showed direct utilization of fatty acyl-CoA donors in N-acylation of Glu1 during surfactin biosynthesis; however, this is thought to be largely mediated by the duel function thioesterase/acyltransferase SrfD instead of the SrfA starter C domain alone.(Steller et al., 2004) This conclusion was supported by the observed binding of myristoyl-CoA to SrfD during structural characterization of SrfD by NMR spectroscopy.(Koglin et al., 2008)

All glidobactins are N-acylated by 2(E),4(E)-dienoic fatty acids which vary in chain length and extent of oxidation. Long chain fatty acids are broken down by sequential removal of two carbon units during β-oxidation, and examination of these intermediates correspond to the novel fatty acids found in the glidobactin natural products. Given that degradation by β-oxidation occurs on CoA thioesters and no ACP was found in the glidobactin gene cluster, we hypothesized that the fatty acids used in glidobactin biosynthesis were activated as CoA thioesters. Alternatively, the CoA intermediate could be transferred to an in trans ACP domain for interaction with the GlbF starter C domain; however, our ability to locate remote ACPs was restricted by the fact that Burkholderia K481-B101 has not been sequenced. Therefore, we synthesized the CoA thioesters of 2(E),4(E)-dodecadienoic acid (glidobactin A, major variant) and 2(E),4(E)-decadienoic acid (glidobactin F, minor variant) to test for direct condensation to Thr1-S-pantetheinyl-GlbF in an end point assay. Reaction products were chemically hydrolyzed from the GlbF T domain and analyzed by HR LC-MS. While no product was detected in the enzyme-free control reactions or with the GlbF H141A mutant, the wild-type enzyme produced both 2(E),4(E) dodecadienoyl-Thr and 2(E),4(E) decadienoyl-Thr (Figure 3). These results confirmed our hypothesis that the starter C domain of GlbF utilizes CoA thioesters as activated fatty acid donors to carry out stoichiometric self modification of Thr1 without requirement for an in trans ACP.

When challenged with variant acyl-CoA donors, GlbF specificity was restricted to use of the singly desaturated 2(E) dodecenoyl-CoA and the long chain palmitoyl- and oleoyl-CoAs (Table 1 and Figure S5-6). Nothing is known about the unusual tailoring that gives rise to the 2(E),4(E) configuration, and it is possible that 2(E) fatty acids undergo subsequent oxidation on the assembly line to generate the diene natural products. Likewise, the significance of the palmitoyl and oleoyl donors is unclear. As the two most common lipids in Burkholderia species (Yabuuchi et al., 1992), palmitoyl- and oleoyl-CoA pools may be substantial enough to generate novel acyl-Thr1-S-pantetheinyl-GlbF intermediates. A detailed kinetic analysis would provide insight into the true selectivity; however, self-acylation of GlbF demands fast reaction/single turnover kinetics currently beyond the scope of our investigation. We suspect the absence of long chain glidobactin variants is due to downstream editing of off-pathway species. Despite this, feeding of methyl linolenate to Burkholderia K481-B101 cultures resulted in isolation of a new glidobactin variant (Numata and Oka 1992). Efforts to explore the promiscuity observed here ultimately requires probing condensation between non-canonical acyl-Thr1-S-pantetheinyl-GlbF intermediates with Lys2-S-pantetheinyl-GlbC in the next downstream module.

One particularly intriguing aspect of this work is the necessity for co-expression of the MbtH-like protein GlbE in order to obtain over-expressed and soluble GlbF (Figure S2). Only ~70 amino acids in length, MbtH-like proteins are found in dozens, but not all, NRPS gene clusters and have remained enigmatic from first observation. Knock-out studies indicate they are essential for production of vicibactin, coelichelin, CDA, clorobiocin, and pyoverdine natural products, yet no catalytic function can be surmised (Carter et al., 2002; Drake et al., 2007; Lautru et al., 2007; Wolpert et al., 2007). The crystal structure of the MbtH-like protein from pyoverdine biosynthesis revealed a novel fold consisting of a 3-stranded antiparallel β-sheet and 2 α-helices (Drake et al., 2007). That study also high-lighted strictly conserved hydrophobic residues, prompting a chaperone function to be proposed.

A recent study in our group on vicibactin biosynthesis found that the MbtH-like protein VbsG was required for adenylation activity of the NRPS VbsS (Heemstra et al., 2009). In that work, it was optimal to co-express VbsG and VbsS which then purified as a complex. When initial efforts to obtain heterologous expression of the NRPS GlbF failed, co-expression of GlbE and GlbF was pursued. Remarkably, direct cloning of the GlbE-GlbF construct from Burkholderia K481-B101 resulted in over-expression of soluble GlbE and GlbF, without modification of the RBS for GlbF or intergenic spacing (Δ 5 bp). In this case, presumably GlbE serves a chaperone function giving rise to the stable formation of the 118 kDa GlbF. We have not yet been able to determine if GlbE is also required for optimal activity, as with the VbsG/VbsS pair, because we were unable to separate the complex in the absence of denaturing detergents. These results prompt continued examination of MbtH-like proteins as activators, chaperones, or both in NRPS assembly lines. Regardless, we find that co-expression of MbtH-like proteins is of practical relevance and should be considered during heterologous expression of NRPS megasynthases.

Significance

N-acylation is an important avenue for diversification of peptide scaffolds and can have profound effects on SAR profiles. Daptomycin, a potent antibiotic in clinical use (as Cubicin) against Gram-positive pathogens including MRSA, was discovered through exploration of fatty acid variations in the constituents of the A21978C complex (Baltz et al., 2005). Likewise, N-acylation of the glidobactin macrolactam core was shown very early on to be critical for antimicrobial and antitumor function (Oka et al., 1988b). More recently, a chimeric syrbactin was produced synthetically by N-acylating the syringolin macrolactam core with a saturated fatty acid resulting in one of the strongest proteasome inhibitors reported to date (Clerc et al., 2009). Despite these examples, biochemical characterization of this step in natural product biosynthesis has remained largely unexplored. The work reported in this communication reveals the necessary components required for N-acylation in the glidobactin family of natural products. The single NRPS module GlbF uses fatty acyl-CoA donors as co-substrates to initiate glidobactin biosynthesis. Furthermore, the importance of the MbtH-like protein GlbE in this work encourages inclusion of MbtH-like proteins during future in vitro characterization of other NRPS systems. Continued investigation into N-acylation tailoring will undoubtedly yield more insight for strategies to bioengineer natural product pathways.

Experimental Procedures

Cloning and Purification of GlbEF

The bicistronic GlbE-GlbF insert was cloned from Burkholderia K481-B101 genomic DNA and ligated into His6-pET vectors for heterologous expression in E. coli BL21 CodonPlus (Stratagen) using standard molecular biology techniques and is detailed in the Supplementary Data. Large scale (2 L) production was carried out at 37°C with IPTG induction (0.5 mM) at an OD600 of 0.4 followed by continued growth at 37°C for an additional 5 hours. Protein was isolated by nickel affinity chromatography as previously described (Imker et al., 2009). Protein was visualized on a 4-15% SDS-PAGE gel, and fractions containing the GlbEF complex in ≥ 95% purity were dialyzed against 250 mM NaCl buffered with 25 mM Tris-HCl at pH 7.9. The protein was concentrated to 7-10 mg/mL as determined by Bradford Assay using BSA as a standard and stored at −80°C until use.

Assay of Condensation Activity

Apo-GlbF (20 μM) was converted to holo-GlbF by incubation with 300 nM B. subtilis Sfp and 200 μM CoA for ~30 minutes in a reaction that contained 5 mM MgCl2, 0.5 mM TCEP, 5 mM Thr, and 40 mM NaCl buffered with 50 mM HEPES-HCl at pH 7.5. The reaction was initiated by addition of ATP and the acyl-CoA to 5 mM and 1.25 mM final concentrations, respectively. The final reaction volume was 250 μL. After two hours, 750 μL of cold methanol was added, and the protein precipitate was pelleted at 10,000 g for 8 minutes. The supernatant was removed, and the pellet washed twice with 250 μL cold methanol. The pellet was dried under an air stream and then dissolved in 125 μL of 0.1 M KOH followed by heating at 70°C for 10 minutes. After cooling to room temperature and neutralization with HCl, the protein was precipitated overnight at −20°C by addition of 1 mL methanol. The hydrolysate was centrifuged at 10,000 g for 15 minutes to remove precipitated protein, and the supernatant concentrated by SpeedVac. The residue was taken up in 100 μL acetonitrile and analyzed by Dual-ESI on an Agilent 6520 QTOF-LCMS in positive ion mode.

Supplementary Material

01

Acknowledgments

LC/MS data was acquired on an Agilent 6520 Q-TOF spectrophotometer supported by the Taplin Funds for Discovery Program (P.I., S. Walker).

Footnotes

Supplemental Data

Supplemental Data includes methods and associated figures for activation and loading assays, amino acid analysis, synthesis of standards and acyl-CoAs, and mass spectrometry spectra and parameters. This material is available online at URL.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Amrein H, Makart S, Granado J, Shakya R, Schneider-Pokorny J, Dudler R. Functional analysis of genes involved in the synthesis of syringolin A by Pseudomonas syringae pv. syringae B301D-R. Molec Plant Microbe Interact. 2004;17:90–97. doi: 10.1094/MPMI.2004.17.1.90. [DOI] [PubMed] [Google Scholar]
  2. Baltz RH, Miao V, Wrigley SK. Natural products to drugs: daptomycin and related lipopeptide antibiotics. Nat Prod Rep. 2005;22:717–741. doi: 10.1039/b416648p. [DOI] [PubMed] [Google Scholar]
  3. Carter RA, Worsley PS, Sawers G, Challis GL, Dilworth MJ, Carson KC, Lawrence JA, Wexler M, Johnston AWB, Yeoman KH. The vbs genes that direct synthesis of the siderophore vicibactin in Rhizobium leguminosarum: their expression in other genera requires ECF sigma factor Rpol. Mol Microbiol. 2002;44:1153–1166. doi: 10.1046/j.1365-2958.2002.02951.x. [DOI] [PubMed] [Google Scholar]
  4. Clerc J, Groll M, Illich DJ, Bachmann AS, Huber R, Schellenberg B, Dudler R, Kaiser M. Synthetic and structural studies on syringolin A and B reveal critical determinants of selectivity and potency of proteasome inhibition. Proc Natl Acad Sci U S A. 2009;106:6507–6512. doi: 10.1073/pnas.0901982106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Drake EJ, Cao J, Qu J, Shah MB, Straubinger RM, Gulick AM. The 1.8 A crystal structure of PA2412, an MbtH-like protein from the pyoverdine cluster of Pseudomonas aeruginosa. J Biol Chem. 2007;282:20425–20434. doi: 10.1074/jbc.M611833200. [DOI] [PubMed] [Google Scholar]
  6. Farnet CM, Staffa A, Zazopoulos E. US Patent 7,235,651. 2007
  7. Gehring AM, Mori I, Walsh CT. Reconstitution and characterization of the Escherichia coli enterobactin synthetase from EntB, EntE, and EntF. Biochemistry. 1998;37:2648–2659. doi: 10.1021/bi9726584. [DOI] [PubMed] [Google Scholar]
  8. Groll M, Schellenberg B, Bachmann AS, Archer CR, Huber R, Powell TK, Lindow S, Kaiser M, Dudler R. A plant pathogen virulence factor inhibits the eukaryotic proteasome by a novel mechanism. Nature. 2008;452:755–758. doi: 10.1038/nature06782. [DOI] [PubMed] [Google Scholar]
  9. Heemstra JR, Walsh CT, Sattely ES. Enzymatic tailoring of ornithine in the biosynthesis of the Rhizobium cyclic trihydroxamate siderophore vicibactin. J Am Chem Soc. 2009;131:15317–15329. doi: 10.1021/ja9056008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Huber FM, Pieper RL, Tietz AJ. The formation of daptomycin by supplying decanoic acid to Streptomyces roseosporus cultures producing the antibiotic complex A21978C. J Biotechnol. 1988;7:283–292. [Google Scholar]
  11. Imker HJ, Walsh CT, Weust WM. SylC catalyzes ureido-bond formation during biosynthesis of the proteasome inhibitor syringolin A. J Am Chem Soc. 2009;131:8263–5. doi: 10.1021/ja909170u. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Koglin A, Löhr F, Bernhard F, Rogov VV, Frueh DP, Strieter ER, Mofid MR, Göntert P, Wagner G, Walsh CT, Marahiel MA, Dötsch V. Structural basis for the selectivity of the external thioesterase of the surfactin synthetase. Nature. 2008;454:907–911. doi: 10.1038/nature07161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kopp F, Linne U, Oberthur M, Marahiel MA. Harnessing the chemical activation inherent to carrier protein-bound thioesters for the characterization of lipopeptide fatty acid tailoring enzymes. J Am Chem Soc. 2008;130:2656–2666. doi: 10.1021/ja078081n. [DOI] [PubMed] [Google Scholar]
  14. Lautru S, Oves-Costales D, Pernodet JL, Challis GL. MbtH-like protein-mediated cross-talk between non-ribosomal peptide antibiotic and siderophore biosynthetic pathways in Streptomyces coelicolor M145. Microbiology-Sgm. 2007;153:1405–1412. doi: 10.1099/mic.0.2006/003145-0. [DOI] [PubMed] [Google Scholar]
  15. Numata K, Murakami T, Oka M, Yamamoto H, Hatori M, Miyaki T, Oki T, Kawaguchi H. Enhanced production of the minor components of glidobactins in Polyangium brachysporum. J Antibiot (Tokyo) 1988;41:1358–1365. doi: 10.7164/antibiotics.41.1358. [DOI] [PubMed] [Google Scholar]
  16. Numata K, Oka M. Glidobactin PF-1 Peptide Antibioitics. U.S. Patent 5,096,884. 1992
  17. Oka M, Nishiyama Y, Ohta S, Kamei H, Konishi M, Miyaki T, Oki T, Kawaguchi H. Glidobactins A, B and C, new antitumor antibiotics. I. Production, isolation, chemical properties and biological activity. J Antibiot (Tokyo) 1988a;41:1331–1337. doi: 10.7164/antibiotics.41.1331. [DOI] [PubMed] [Google Scholar]
  18. Oka M, Numata K, Nishiyama Y, Kamei H, Konishi M, Oki T, Kawaguchi H. Chemical modification of the antitumor antibiotic glidobactin. J Antibiot (Tokyo) 1988b;41:1812–1822. doi: 10.7164/antibiotics.41.1812. [DOI] [PubMed] [Google Scholar]
  19. Quadri LEN, Weinreb PH, Lei M, Nakano MM, Zuber P, Walsh CT. Characterization of Sfp, a Bacillus subtilis phosphopantetheinyl transferase for peptidyl carrier protein domains in peptide synthetases. Biochemistry. 1998;37:1585–1595. doi: 10.1021/bi9719861. [DOI] [PubMed] [Google Scholar]
  20. Rausch C, Weber T, Kohlbacher O, Wohlleben W, Huson DH. Specificity prediction of adenylation domains in nonribosomal peptide synthetases (NRPS) using transductive support vector machines (TSVMs) Nucleic Acids Res. 2005;33:5799–5808. doi: 10.1093/nar/gki885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rausch C, Hoof I, Weber T, Wohlleben W, Huson DH. Phylogenetic analysis of condensation domains in NRPS sheds light on their functional evolution. BMC Evol Biol. 2007;7:78. doi: 10.1186/1471-2148-7-78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Schellenberg B, Bigler L, Dudler R. Identification of genes involved in the biosynthesis of the cytotoxic compound glidobactin from a soil bacterium. Environ Microbiol. 2007;9:1640–1650. doi: 10.1111/j.1462-2920.2007.01278.x. [DOI] [PubMed] [Google Scholar]
  23. Stachelhaus T, Mootz HD, Bergendahl V, Marahiel MA. Peptide bond formation in nonribosomal peptide biosynthesis - Catalytic role of the condensation domain. J Biol Chem. 1998;273:22773–22781. doi: 10.1074/jbc.273.35.22773. [DOI] [PubMed] [Google Scholar]
  24. Stachelhaus T, Mootz HD, Marahiel MA. The specificity-conferring code of adenylation domains in nonribosomal peptide synthetases. Chem Biol. 1999;6:493–505. doi: 10.1016/S1074-5521(99)80082-9. [DOI] [PubMed] [Google Scholar]
  25. Steller S, Sokoll A, Wilde C, Bernhard F, Franke P, Vater J. Initiation of surfactin biosynthesis and the role of the SrfD-thioesterase protein. Biochemistry. 2004;43:11331–11343. doi: 10.1021/bi0493416. [DOI] [PubMed] [Google Scholar]
  26. Waspi U, Blanc D, Winkler T, Ruedi P, Dudler R. Syringolin, a novel peptide elicitor from Pseudomonas syringae pv. syringae that induces resistance to Pyricularia oryzae in rice. Mol Plant Microbe Interact. 1998;11:727–733. [Google Scholar]
  27. Wolpert M, Gust B, Kammerer B, Heide L. Effects of deletions of mbtH-like genes on clorobiocin biosynthesis in Streptomyces coelicolor. Microbiology-Sgm. 2007;153:1413–1423. doi: 10.1099/mic.0.2006/002998-0. [DOI] [PubMed] [Google Scholar]
  28. Yabuuchi E, Kosako Y, Oyaizu H, Yano I, Hotta H, Hashimoto Y, Ezaki T, Arakawa M. Proposal of Burkholderia gen. nov. and Transfer of Seven Species of the Genus Pseudomonas Homology Group II to the New Genus, with the Type Species Burkholderia cepacia (Palleroni And Holmes 1981) comb. nov. Microbiol Immunol. 1992;36:1251–1275. doi: 10.1111/j.1348-0421.1992.tb02129.x. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

01

RESOURCES